| Axon ID |
Name |
Description |
From price |
|
1398
|
Sunitinib malate
|
Multi-targeted receptor tyrosine kinase inhibitor |
€80.00 |
|
1411
|
Vandetanib
|
VEGFR and EGFR tyrosine kinase inhibitor |
€50.00 |
|
1414
|
AG 013736
|
PDGFR,c-KIT and VEGFR tyrosine kinase inhibitor |
€50.00 |
|
1420
|
Pazopanib hydrochloride
|
PDGFR, c-KIT and VEGFR tyrosine kinase inhibitor |
€60.00 |
|
1461
|
Cediranib
|
VEGFR tyrosine kinase inhibitor |
€70.00 |
|
1540
|
VX 680
|
Aurora inhibitor (non-specific) |
€60.00 |
|
1541
|
ZM 447439
|
Aurora B inhibitor |
€85.00 |
|
1547
|
OSI 930
|
c-Kit and VEGFR2 tyrosine kinase inhibitor |
€90.00 |
|
1580
|
AZD1152-HQPA
|
Aurora B inhibitor |
€70.00 |
|
1597
|
Aurora A inhibitor I
|
Aurora A inhibitor |
€125.00 |
|
1630
|
Aurora A inhibitor II
|
Aurora A inhibitor |
€125.00 |
|
1637
|
Vatalanib
|
VEGFR tyrosine kinase inhibitor |
€75.00 |
|
1638
|
ABT 869
|
PDGFR, c-KIT and VEGFR tyrosine kinase inhibitor |
€85.00 |
|
1653
|
AEE 788
|
EGFR, ErbB2 and VEGFR tyrosine kinase inhibitor |
€80.00 |
|
1662
|
CP 547632
|
VEGFR2 tyrosine kinase inhibitor |
€70.00 |
|
1678
|
Regorafenib
|
Multi-kinase RTK inhibitor |
€70.00 |
|
1717
|
Tivozanib
|
VEGFR1, 2, and 3 tyrosine kinase inhibitor |
€80.00 |
|
1768
|
AMG 706
|
Multiple receptor tyrosine kinase inhibitor |
€105.00 |
|
1783
|
AMG 900
|
Aurora inhibitor (non-specific) |
€110.00 |
|
1819
|
Cabozantinib S-malate
|
Inhibitor of multiple receptor tyrosine kinases, specifically MET and VEGFR2 |
€60.00 |
|
1836
|
CCT 137690
|
Aurora inhibitor (non-specific) |
€115.00 |
|
1850
|
BMS 540215
|
Inhibitor of VEGFR (subtype 2 and 3 selective) |
€110.00 |
|
1864
|
Brivanib alaninate
|
Prodrug of BMS 540215; Inhibitor of VEGF |
€90.00 |
|
1891
|
SU 6668
|
Inhibitor of RTK targeting PDGFR, VEGF and FGFR |
€100.00 |
|
1942
|
E 3810 dihydrochloride
|
Dual VEGFR/FGFR tyrosine kinase inhibitor |
€90.00 |
|
1959
|
Golvatinib
|
Potent and orally available inhibitor of c-MET (HGFR) and VEGFR2 |
€90.00 |
|
1961
|
MK 5108
|
Inhibitor of Aurora A kinase |
€110.00 |
|
1963
|
LY 573636
|
Anti-tumor agent; causes growth arrest and apoptosis |
€80.00 |
|
1978
|
ZM 323881 hydrochloride
|
Inhibitor of VEGFR2 |
€105.00 |
|
2003
|
MLN8237
|
Second generation selective Aurora A inhibitor |
€90.00 |
|
2023
|
PF 03814735
|
ATP-competitive inhibitor of aurora kinase A and B |
€120.00 |
|
2096
|
Hesperadin
|
Reversible and ATP-competitive inhibitor of Aurora B |
€95.00 |
|
2219
|
AT 9283
|
Multitargeted kinase inhibitor (Aurora A/B, JAK2/3, and BCR-Abl) |
€85.00 |
|
1667
|
SU 5402
|
Fibroblast growth factor receptor (FGFR) inhibitor |
€60.00 |
|
2648
|
Nintedanib
|
RTK inhibitor with antiangiogenic and antineoplastic activities |
€70.00 |
|
2767
|
SU11652
|
Multi-targeted receptor tyrosine kinase inhibitor |
€140.00 |
|
2849
|
Apatinib
|
Inhibitor of VEGFR2 |
€120.00 |
|
2865
|
NVP-ACC789
|
Inhibitor of VEGFR2 |
€90.00 |
|
2906
|
SNS 314 mesylate
|
Potent and selective Aurora inhibitor (non-specific) |
€90.00 |
|
2837
|
BMS 605541
|
Potent, selective, orally active, and ATP-competitive VEGFR2 inhibitor |
€90.00 |
|
3165
|
Lenvatinib
|
Multi-targeted receptor tyrosine kinase inhibitor |
€70.00 |
|
3408
|
AKI603
|
Inhibitor of Aurora A kinase |
€145.00 |
|
3338
|
Taxifolin
|
Inhibitor of VEGFR2 |
€50.00 |
|
3624
|
Toceranib phosphate
|
Multi-targeted receptor tyrosine kinase inhibitor |
€60.00 |
|
3758
|
LY-3295668
|
Orally available, potent and highly selective Aurora A kinase (AurA) inhibitor |
Inquire |
|
3920
|
GSK1070916
|
Potent, selective and ATP competitive inhibitor of Aurora B and C kinases |
€110.00 |
|
3946
|
Altiratinib
|
Balanced inhibitor for MET, TIE2 (TEK), and VEGFR2 (KDR) kinases |
Inquire |
|
3998
|
MGCD516
|
Orally bioavailable receptor tyrosine kinase (RTK) inhibitor |
Inquire |